Levisonics
Private Company
Total funding raised: $3.7M
Overview
Levisonics is a privately-held, pre-revenue medical device company based in Cambridge, Massachusetts, specializing in diagnostic platform development. The company leverages academic research to create tools for precise blood coagulation and rheological analysis, targeting unmet needs in clinical diagnostics and drug delivery. With a small, PhD-heavy leadership team, Levisonics is in the early stages of technology development and validation. Its success hinges on translating its novel measurement platform into a commercially viable product for clinical and research markets.
Technology Platform
Novel platform for blood coagulation analysis and fluid rheological measurement, likely based on acoustics, microfluidics, or optical techniques derived from academic research.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
The coagulation diagnostics market is dominated by major players like Abbott, Werfen, Roche, and Haemonetics. Competition is based on assay menu, speed, ease-of-use, and integration into clinical workflows. Levisonics must demonstrate clear advantages in performance, cost, or application to overcome high barriers to entry.